Madd Money (Free subscription) | 11/05/2009
“Celgene Corp (CELG) is a buy, but not yet,” Jim Cramer said, “investors should wait for the right moment before rushing in.” The biotech giant was the third name that Cramer added to his portfolio of cancer-fighting drug companies after Pfizer Inc. (PFE) and Bristol-Myers Squibb Company (BMY). Cramer went up against his colleague at [...]
Business Wire (Free subscription) | 10/30/2009
SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) today announced its presentation at the Oppenheimer & Co. Inc. 20th Annual Healthcare Conference on Wednesday, November 4, 2009 at 10:15 a.m. ET will be webcast live and will be available in the investor relations section of the company’s Web site at www.celgene.com. Celgene management will provide an overview of the company....
Market Wire (Free subscription) | 10/26/2009
NEW DELHI, INDIA (MARKET WIRE) Analyst Choice has combined some of the best financial and technical minds worldwide to bring you an array of free quality equity research and reporting. Today we have begun in-depth reporting on our website evaluating the current market condition of Arena Pharmaceuticals Inc. (NASDAQ: ARNA), Celgene Corporation (NASDAQ: CELG), TiVo Inc. (NASDAQ: TIVO), GenVec Inc. (NASDAQ:...
SeekingAlpha.com (Free subscription) | 10/22/2009
Celgene Corporation ( CELG ) Q3 2009 Earnings Call Transcript October 22, 2009 9:00 am ET Complete Story »
Business Wire (Free subscription) | 10/22/2009
SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ:CELG): 2009 Third Quarter Financial Results Year-Over-Year: Non-GAAP Total Revenue Increased 18 Percent to $692 Million; GAAP Total Revenue $695 Million REVLIMID Net Product Sales Increased 31 Percent to $450 Million VIDAZA Net Product Sales Increased 62 Percent to $103 Million THALOMID® Net Product Sales Totaled $110 Million Non-GAAP Operating...
Medical News Today (Free subscription) | 10/21/2009
Celgene Corporation (NASDAQ: CELG) announced that updated results of a phase II, multi-center, randomized, double-blind, placebo-controlled, three-arm study of apremilast in adult patients with psoriatic arthritis (CC-10004-PSA-001) were presented today at the American College of Rheumatology (ACR) 2009 annual meeting in Philadelphia, PA.
Business Wire (Free subscription) | 10/20/2009
SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) announced that updated results of a phase II, multi-center, randomized, double-blind, placebo-controlled, three-arm study of apremilast in adult patients with psoriatic arthritis (CC-10004-PSA-001) were presented today at the American College of Rheumatology (ACR) 2009 annual meeting in Philadelphia, PA. Apremilast is an oral pluripotent...
Cara Community - Comments (Free subscription) | 10/15/2009
In reply to Cara's Commentary & Community Chat, Thursday, Oct. 15, 2009 : Rating Company Name Symbol 1.0 Ryanair Holdings plc RYAAY 1.4 Stericycle, Inc. SRCL 1.5 Activision Blizzard, Inc ATVI 1.6 Teva Pharmaceutical Industries Limited TEVA 1.6 Warner Chilcott plc WCRX 1.7 Cognizant Technology Solutions Corp CTSH 1.7 Express Scripts, Inc. ESRX 1.7 Gilead Sciences, Inc. GILD 1.8 Foster Wheeler AG....
Market Wire (Free subscription) | 10/15/2009
LONDON (MARKET WIRE) Benchmark Journal brings independent company and sector research together, utilizing top financial advisors and investment tactics to provide you with a clear picture of investment opportunities. Today we began research on Liz Claiborne Inc. (NYSE: LIZ), Allied Capital Corporation (NYSE: ALD), MDU Resources Group Inc. (NYSE: MDU), Pulte Homes Inc. (NYSE: PHM), Celgene Corporation...
Business Wire (Free subscription) | 10/13/2009
SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) senior management will host a conference call and live audio webcast on Thursday, October 22, 2009 at 9 a.m. EDT to discuss the company’s third quarter financial and operational results. The webcast will be available in the investor relations section of the company's Web site at www.celgene.com. Celgene Corporation, headquartered...
iStockAnalyst.com (Free subscription) | 10/12/2009
Celgene Corporation is scheduled to report its third quarter financial results on Thursday, October 22. [More...]
Business Wire (Free subscription) | 09/30/2009
SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) today announced its presentation at the JMP Securities Fourth Annual Healthcare Focus Conference on Monday, October 5, 2009 at 1:30 p.m. ET will be webcast live and will be available in the investor relations section of the company’s Web site at www.celgene.com. Celgene management will provide an overview of the company. Celgene...
Market Wire (Free subscription) | 09/23/2009
NEW DELHI, INDIA (MARKET WIRE) W.S.S. is an online community with a dedicated team of analysts who are providing free in-depth research on North American equities. Our analysts have issued free ratings reports on the following six companies: Tibco Software Inc. (NASDAQ: TIBX), GT Solar International Inc. (NASDAQ: SOLR), Apollo Investment Corporation (NASDAQ: AINV), Solarfun Power Holdings Co. Ltd....
Business Wire (Free subscription) | 09/17/2009
SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) today announced its presentation at the UBS Global Life Sciences Conference on Tuesday, September 22, 2009 at 1:30 p.m. ET will be webcast live and will be available in the investor relations section of the company’s Web site at www.celgene.com. Celgene management will provide an overview of the company. Celgene Corporation, headquartered...
Market Wire (Free subscription) | 08/27/2009
NEW DELHI, INDIA (MARKET WIRE) Analyst Choice has combined some of the best financial and technical minds worldwide to bring you an array of free quality equity research and reporting. Today we have begun in-depth reporting on our website evaluating the current market condition of Celgene Corporation (NASDAQ: CELG), eBay Inc. (NASDAQ: EBAY), The Gymboree Corporation (NASDAQ: GYMB), E TRADE Financial...
Videos